Datasets Comparison

Table of Contents for “Prevalence, Incidence, and Risk Factors for Dermatologic Conditions in People with HIV in the Modern Antiretroviral Era: A Cohort Study in Washington, DC” Supplemental Table 1. Frequency of conditions by dermatologic condition categories. Sub-categories are presented as part of each category of HIV-associated malignancies, inflammatory conditions, and infectious diseases. Supplemental Table 2. Characteristics of participants with any dermatologic conditions (N=5,794). Supplemental Methods for Supplemental Figure 1. Annual incidence was assessed among all participants at risk, defined as those without a DD at baseline who remained engaged in care during the calendar year; individuals developing a DD were excluded from risk calculations in subsequent years. A chi-square test compared incident DDs between 2011 and 2024 among all eligible participants. Supplemental Figure 1. Comparison of incident DDs among all participants at risk in 2011 and 2024 Supplemental Table 3. Results of Unadjusted Risk Factors Associated with Dermatologic Conditions in PWH

Dermatology, Epidemiology, Human Immunodeficiency Virus, Antiretroviral Agent, Cohort Study, Skin Disease, HIV/AIDS

Creative Commons Attribution 4.0 International

Table of Contents for Supplemental Materials for “Prevalence, Incidence, and Risk Factors for Dermatologic Conditions in People with HIV in the Modern Antiretroviral Era: A Cohort Study in Washington, DC” Supplemental Table 1. Frequency of conditions by dermatologic condition categories. Sub-categories are presented as part of each category of HIV-associated malignancies, inflammatory conditions, and infectious diseases. Supplemental Table 2. Characteristics of participants with any dermatologic conditions (N=5,794). Supplemental Methods for Supplemental Figure 1. Annual incidence was assessed among all participants at risk, defined as those without a DD at baseline who remained engaged in care during the calendar year; individuals developing a dermatologic disease (DD) were excluded from risk calculations in subsequent years. A chi-square test compared incident DDs between 2011 and 2024 among all eligible participants. Supplemental Figure 1. Comparison of incident DDs among all participants at risk in 2011 and 2024 Supplemental Table 3. Risk factors associated with cutaneous skin manifestations in PWH (Unadjusted analysis)

Dermatology, Epidemiology, Human Immunodeficiency Virus, Antiretroviral Agent, Cohort Study, Skin Disease, HIV/AIDS

Creative Commons Attribution 4.0 International